Stay updated on Subcutaneous Ocrelizumab in Multiple Sclerosis Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Ocrelizumab in Multiple Sclerosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Ocrelizumab in Multiple Sclerosis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.0 to v3.6.2, signaling a subsequent update to the page's content or presentation.
    Difference
    0.0%
    Check dated 2026-06-27T07:38:12.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now indicates no further participant recruitment and introduces new user-help sections for reading the study record and joining, along with a revision label; a formatting change to the Intervention/Treatment heading is also applied.
    Difference
    0.4%
    Check dated 2026-06-13T04:32:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page content. This appears to be a metadata/software update that does not change the study details, eligibility, or results.
    Difference
    0.0%
    Check dated 2026-06-05T22:02:21.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4. This indicates a new version of the page without changes to the study details.
    Difference
    0.0%
    Check dated 2026-05-15T15:01:03.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A Publications section was added, listing a PubMed citation for Subcutaneous ocrelizumab in multiple sclerosis and noting that these publications are automatically filled from PubMed.
    Difference
    0.2%
    Check dated 2026-05-08T11:45:05.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-24T05:49:29.000Z thumbnail image

Stay in the know with updates to Subcutaneous Ocrelizumab in Multiple Sclerosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Ocrelizumab in Multiple Sclerosis Clinical Trial page.